Pectin-Lyase-Modified Ginseng Extract and Ginsenoside Rd Inhibits High Glucose-Induced ROS Production in Mesangial Cells and Prevents Renal Dysfunction in Db/db Mice
Overview
Authors
Affiliations
Diabetes increases the incidence rate of chronic renal disease. Pectin-lyase-modified ginseng (GS-E3D), with enhanced ginsenoside Rd content, has been newly developed. In this study, renal protective roles of GS-E3D in type-2 diabetic db/db mice were investigated. The generation of reactive oxygen species (ROS) induced by high glucose (25 mM) was reduced by ES-E3D (75%) and ginsenoside Rd (60%). Diabetic db/db mice received 100 or 250 mg/kg/day of GS-E3D daily via oral gavage for 6 weeks. Albuminuria and urinary 8-hydroxy-2'-deoxyguanosine (8-OhdG, an oxidative stress marker) levels were increased in db/db mice and the levels recovered after GS-E3D treatment. In renal tissues, TUNEL-positive cells were decreased after GS-E3D treatment, and the increased apoptosis-related protein expressions were restored after GS-E3D treatment. Therefore, GS-E3D has a potent protective role in diabetes-induced renal dysfunction through antioxidative and antiapoptotic activities. These results may help patients to select a dietary supplement for diabetes when experiencing renal dysfunction.
Ginseng extract improves pancreatic islet injury and promotes β-cell regeneration in T2DM mice.
Yin J, Huang Y, Wang K, Zhong Q, Liu Y, Ji Z Front Pharmacol. 2024; 15:1407200.
PMID: 38989151 PMC: 11234855. DOI: 10.3389/fphar.2024.1407200.
Li J, Huang Q, Yao Y, Ji P, Mingyao E, Chen J Front Pharmacol. 2022; 13:909363.
PMID: 35928281 PMC: 9343777. DOI: 10.3389/fphar.2022.909363.
Insights into Recent Studies on Biotransformation and Pharmacological Activities of Ginsenoside Rd.
Song X, Wang L, Fan D Biomolecules. 2022; 12(4).
PMID: 35454101 PMC: 9031344. DOI: 10.3390/biom12040512.